Andrographis dropped from listed medicines framework

Sponsors of listed medicines containing Andrographis are being "strongly encouraged" to withdraw their products following a TGA decision  New medicines containing Andrographis paniculata (Andrographis) are no longer eligible for listing on the Australian Register of Therapeutic Goods (ARTG), following a safety review earlier this year.   The Therapeutic Goods Administration (TGA) announced the decision to remove